The Senior Managing Director at Laidlaw & Co. and Managing Partner of Laidlaw Venture Partners, Patrick Gallagher, CFA is an accomplished Capital Markets Executive, Advisor, and Investor with a distinguished record of success in both the public and private markets. He serves as the Chief Executive Officer of two life sciences companies, Voltron Therapeutics and PD Theranostics. Patrick has over 25 years of experience on Wall Street and extensive expertise in alternative investments, research, and marketing. Previously, he was a founding partner and Chief Executive Officer of BDR Research Group, LLC., a healthcare focused institutional research boutique that specialized in providing services for clients in the healthcare investing, financing, and operations areas. Pat has decades of experience in the biotech and med tech industries at the operating and board level.
Listed skills include Management, Biotechnology, Financial Analysis, Sales, and 46 others.